Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread [Phase 2]
Phase 2 trial update evaluating two regimens for older patients with metastatic pancreatic cancer: gemcitabine plus nab-paclitaxel versus a …
-
CLINICAL_TRIALS other · 2026-03-23Clinical Trial Update: Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic Cancer [Phase 1]
Open-label, Phase 1 neoadjuvant trial evaluating nogapendekin alfa inbakicept, sotevtamab, and zabadinostat in combination with gemcitabine …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 first-in-human study of IPH5301, an anti-CD73 antibody, given alone or with chemotherapy and trastuzumab, in patients with advance…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer [Phase 1]
Phase 1 trial of NBTXR3 activated by radiation therapy for borderline resectable or locally advanced pancreatic cancer has been suspended.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial) [NA]
A Phase II clinical trial evaluating radiotherapy for locally advanced pancreatic cancer is currently recruiting. No results are reported ye…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Evaluation of Resection Techniques for Pancreatic Tumors
A study evaluating surgical resection techniques for pancreatic tumors is currently recruiting, sponsored by Methodist Health System.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer [NA]
A clinical trial evaluating preoperative proton radiotherapy combined with chemotherapy for borderline resectable pancreatic cancer; the stu…
-
EMA approval · 2026-03-19EMA Authorised: Lynparza (olaparib) — AstraZeneca AB
The EMA authorised Lynparza (olaparib) for multiple cancers in the European Union. Indications include ovarian cancer, breast cancer, pancre…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients [Phase 1]
Phase 1 trial of Cabotamig (ARB202) in advanced gastrointestinal cancers has completed; no specific efficacy results are provided in the doc…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients [Phase 1, Phase 2]
This update reports on a Phase 1/2 trial of peripheral blood lymphocytes transduced with a murine T-cell receptor recognizing the G12D varia…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
A Pan-European post-authorization safety study evaluating whether initiating exenatide in type 2 diabetes patients is associated with a diff…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma [EARLY_Phase 1]
An early-phase trial evaluating cholesterol-disruption in combination with standard of care for advanced pancreatic ductal adenocarcinoma; t…
-
CLINICAL_TRIALS other · 2026-03-19Clinical Trial Update: Autologous CAR-T Cells Targeting B7-H3 in PDAC [Phase 1]
An ongoing Phase 1 clinical trial is evaluating autologous CAR-T cells targeting B7-H3 for pancreatic cancer, and recruitment is currently o…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies [Phase 1]
Phase 1 clinical trial evaluating RSC-1255 in patients with advanced malignancies carrying RAS mutations, sponsored by RasCal Therapeutics, …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Resilience and Equity in Aging, Cancer, and Health (REACH) [NA]
The REACH trial sponsored by Dana-Farber Cancer Institute is currently recruiting. It targets multiple gastrointestinal cancers including ga…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for FMC-376 in KRAS G12C-mutated solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Tumour Regulatory Molecules in Early Pancreatic Cancer Detection
An ongoing clinical trial, sponsored by Hull University Teaching Hospitals NHS Trust, is investigating tumour regulatory molecules for early…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic Cancer [NA]
This clinical trial update describes a study evaluating whether hypertrophy-oriented resistance training can improve muscle mass and quality…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Access to Genetic Testing in Underserved Patients With Cancer [NA]
This entry reports on a clinical trial investigating access to genetic testing for cancer patients in underserved populations, with recruitm…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Early Phase Study of KESONOTIDE™in Participants With Solid Tumours [Phase 1, Phase 2]
KESONOTIDE is being studied in an early-phase (Phase 1/Phase 2) trial for solid tumours and is currently recruiting across multiple cancer i…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions. [NA]
The study aims to identify biomarkers that distinguish malignant pancreatic lesions from benign pancreatic lesions.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Reinforced Pancreaticojejunostomy With or Without glubran2 [Phase 2]
A Phase 2 clinical trial evaluating reinforced pancreaticojejunostomy with or without Glubran2 surgical adhesive in pancreatic and periampul…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach [NA]
Ongoing recruitment for a clinical trial evaluating stereotactic adaptive radiation therapy for border-line resectable pancreatic cancer, sp…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
A feasibility study sponsored by Origin Sciences is recruiting to investigate rectal mucus in aero-digestive tract cancers, including Non-Sm…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study of Suizenji in Patients With Unresectable Pancreatic Cancer [NA]
Clinical trial update for Suizenji in patients with unresectable pancreatic cancer; the study is currently active but not recruiting.